New study expanded understanding of influenza-associated complications
On Mar. 20, 2020, a study was published in JAMA that expands the understanding of influenza-associated complications. Influenza…
On Mar. 20, 2020, a study was published in JAMA that expands the understanding of influenza-associated complications. Influenza…
On Mar. 20, 2020, Cardax released a white paper outlining the potential role of astaxanthin in the treatment…
On Mar. 20, 2020, Amneal Pharma announced that it was responding to the national COVID-19 health emergency by…
On Mar. 20, 2020, the University of Pennsylvania announced that Pavilion project construction would be allowed to continue…
On Mar. 19, 2020, Roche announced it was working with the U.S. Food & Drug Administration (FDA) to…
On Mar. 19, 2020, The UArizona Cancer Center announced it was awarded a five-year, $6.9 million prestigious Program…
On Mar. 19, 2020, Gilead Sciences announced the U.S. Food and Drug Administration (FDA) had approved a supplemental…
On Mar. 19, 2020, Mesa Biotech announced it had been awarded a $561,000 contract from the U.S. Department…
On Mar. 19, 2020, the Mayo Clinic announced it had significantly expanded its capacity to test clinical samples…
On Mar. 19, 2020, Teva announced the immediate donation of more than 6 million doses of hydroxychloroquine sulfate…
On Mar. 19, 2020, Todos Medical announced it had entered into an exclusive distribution agreement for the U.S….
On Mar. 19, 2020, Mylan announced it had restarted production of hydroxychloroquine sulfate tablets at its West Virginia…
On Mar. 18, 2020, StartX, a non-profit startup community of more than 1500 Stanford faculty and alumni founders,…
On Mar. 18, 2020, scientists from the University of Oxford’s Engineering Science Department and the Oxford Suzhou Centre…
On Mar. 18, 2020, Mateon Therapeutics reported significant progress in deploying its phase 3 clinical asset, OT-101, against…
On Mar. 17, 2020, researchers at the National Eye Institute (NEI) reported finding a protein that normally deposits…
On Mar. 17, 2020, CanSino Biologics announced that its recombinant novel Coronavirus Vaccine (Adenovirus Type 5 Vector) candidate…
On Mar. 17, 2020, Israel’s Health Ministry announced that it had approved a request by Pluristem Therapeutics to…
On Mar. 17, 2020, Quidel Corp. announced it had received Emergency Use Authorization (EUA) from the U.S. Food…
On Mar. 17, 2020, MannKind announced it is adjusting research and development resources that were reserved for its…
On Mar. 17, 2020, Regeneron announced that its scientists had isolated hundreds of virus-neutralizing, fully human antibodies from…
On Mar. 17, 2020, Todos Medical announced a non-exclusive distribution agreement with 3D Biomedicine Science & Technology, a…
On Mar. 16, 2020, Hologic announced the U.S. Food and Drug Administration (FDA) had granted Emergency Use Authorization…
On Mar. 16, 2020, BD (Becton, Dickinson and Company) announced the companies had submitted Emergency Use Authorization requests…
On Mar. 16, 2020, OpGen reported an update on the business of Curetis, the other party to the…
On Mar. 16, 2020, Sanofi and Regeneron Pharma announced they have started a clinical program evaluating Kevzara (sarilumab)…
On Mar. 16, 2020, the Hormel Institute, University of Minnesota announced published research concerning remnants of ancient viruses…
On Mar. 16, 2020, the National Institutes of Health (NIH announced that a Phase 1 clinical trial evaluating…
On Mar. 16, 2020, new insights into the architecture of the brain were revealed by scientists at the…
On Mar. 16, 2020, Aimmune Therapeutics announced that the first patients in the U.S. were being treated with…